There are significant differences in the clinical course between patients with es and those with idiopathic pulmonary hypertension.
ES病人和特发性肺动脉高压病人的临床过程有显著的差异。
Patients with ES show significantly more favorable survival rates, as compared with those with untreated idiopathic pulmonary hypertension.
ES病人与那些未经治疗的特发性肺动脉高压病人比较，生存率更佳。
Hemoptysis, erythrocytosis, brain abscesses, coagulation abnormalities, and cerebrovascular incidents are commonly associated with es and not with idiopathic pulmonary hypertension.
咯血、红细胞增多、脑脓肿、凝血异常以及脑血管意外等常与ES相关，而与特发性肺动脉高压病人相关少。
Anticoagulants, which are an important part of therapy for many patients with idiopathic pulmonary hypertension, are controversial in ES, because of the high risk for bleeding complications.
抗凝治疗对特发性肺动脉高压病人十分重要，但是在治疗ES方面存在争论，因为出血风险高。
Anticoagulants, which are an important part of therapy for many patients with idiopathic pulmonary hypertension, are controversial in ES, because of the high risk for bleeding complications.
抗凝治疗对特发性肺动脉高压病人十分重要，但是在治疗ES方面存在争论，因为出血风险高。
应用推荐